| FXAIX | QGIAX | FXAIX / QGIAX | |
| Total Expense Ratio | 0.01 | 0.74 | 2% |
| Annual Report Gross Expense Ratio | 0.01 | 1.27 | 1% |
| Fund Existence | 15 years | 35 years | - |
| Gain YTD | 12.437 | 10.936 | 114% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 833B | 253M | 329,249% |
| Annual Yield % from dividends | 1.06 | 0.65 | 163% |
| Returns for 1 year | 21.35 | -2.52 | -847% |
| Returns for 3 years | 81.15 | 20.31 | 400% |
| Returns for 5 years | 84.67 | 4.38 | 1,933% |
| Returns for 10 years | 286.57 | 56.62 | 506% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RDWU | 8.10 | 0.27 | +3.45% |
| T-REX 2X LONG RDW DAILY TARGET ETF | |||
| PJP | 130.03 | 1.14 | +0.89% |
| Invesco Pharmaceuticals ETF | |||
| IWX | 112.30 | 0.48 | +0.43% |
| iShares Russell Top 200 Value ETF | |||
| SIHY | 45.29 | 0.06 | +0.13% |
| Harbor Ares Systematic High-Yield ETF | |||
| CPHY | 51.81 | 0.05 | +0.09% |
| F/m Compoundr High Yield Bond ETF | |||